CO-ADMINISTRATION OF KETOCONAZOLE, A POTENT CYP3A4 INHIBITOR, DOES NOT AFFECT SAFETY OR TOLERABILITY OF YM905

Smith N. 1, van Zijtveld J. 2, Swart P. J. 2 1. Yamanouchi USA, 2. Yamanouchi Europe B.V.

Abstract Category

Pharmacology: Clinical

Abstract 447
Non Discussion Poster
Scientific Non Discussion Poster Session 18
Links

Abstract

28/04/2024 16:02:35